Published in Medical Patent Week, April 29th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Sigma-Aldrich.
Report 1: SAFC, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), announced today that it has completed the initial phase of a two-stage expansion at its SAFC Pharmorphix(TM) research facility in Cambridge, U.K., for its SAFC Pharma business. Completion of a 2,500 sq. ft. laboratory extension will be followed by additional investment in spring 2007 as part of a $600,000 expansion program.
SAFC Pharmorphix is one of a few organizations specializing in solid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.